The PROPOSE RCT is a two-arm randomized controlled trial that will be conducted to test the efficacy of a personalized, multidisciplinary pre-operative prehabilitation program (preventive prehabilitation) to reduce serious complications and facilitate recovery after surgery in high-risk patients. The multimodal prehabilitation program is a preoperative intervention that includes exercise training, nutritional therapy and anxiety reduction techniques, with the aim of preventing or mitigating the functional decline brought about by surgery. 400 patients scheduled for elective major abdominal (including urological), thoracic (including breast) or gynecological cancer surgery will be enrolled. They will be randomized (1:1 ratio) and assigned either to the intervention group (Prehabilitation) or to the control group, which will only be treated according to the usual standard of care within the Enhanced Recovery After Surgery (ERAS) pathways.
The standard treatment for most solid cancer includes surgery and concurrent medical therapies, both of which have been shown to significantly improve prognosis. However, cancer treatments impose impactful physiological stress and have detrimental effects on acute and long-term health outcomes. Physical, nutritional, and mental status can influence surgical outcomes, functional recovery and quality of life throughout the course of the disease. The importance of postoperative rehabilitation on physical performance and recovery is well-recognized. However, the preoperative period provides a unique opportunity to address comorbidities and modifiable risk factors. In addition, the metabolic stress induced by neoadjuvant therapy has been documented to frequently result in muscle atrophy and diminished functional capacity. The recognition that selected risk factors of poor postoperative outcome can be modified has prompted clinicians to identify proactive interventions to facilitate the recovery process. In this context, prehabilitation, aimed at enhancing the patients' functional capacity to enable them to withstand the physiological stress of surgery, has emerged as a promising approach. Although the term prehabilitation is not novel, the concept of optimizing patients before acute stressor or treatment has gained attention over the last decade. Nonetheless, quantifiable evidence of its effectiveness has yet to be fully demonstrated. This study is a multicenter randomized controlled trial to assess the efficacy of personalized procedure-specific prehabilitation programs on patient-centered surgical outcomes. A total of 400 patients will be recruited by systematic screening of patients scheduled for elective surgical procedures. All patients undergoing elective major abdominal (including urological), thoracic (including breast) or gynecological cancer surgery undergoing major cancer surgery will be screened for eligibility and those who meet the inclusion/exclusion criteria will be approached for consent. Research personnel will use a web-based randomization system to assign patients (1:1 ratio) to either the prehabilitation or control arm. Study personnel will also collect data on recruitment rates, with reasons for non-enrolment. Eligible patients will be randomly assigned to 1 of 2 treatments: 1. multimodal prehabilitation program for at least three weeks started as soon as possible before surgery; 2. standard care. The multimodal prehabilitation program will be individualized by carefully integrating and adapting various components to meet individual needs. The program will last at least three weeks (plus maintenance in case of delayed surgery), and will incorporate exercise training, nutritional therapy, and anxiety reduction techniques. After enrollment, patients will receive initial contact from trained personnel through telemedicine. To ensure personalized care, a comprehensive assessment will be conducted to identify specific physical, nutritional, or psychological challenges. Based on this assessment, a customized intervention plan will be prescribed to achieve tailored exercise training, optimized nutrition, and effective distress-coping strategies. All patients will be reassessed the day before surgery and 30 days after surgery. Based on the data obtained during the multimodal assessment, different domains and levels of care will be prescribed, focusing on exercise training, nutrition optimization, or distress-coping techniques-or a combination of these
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
400
A tailored intervention will be prescribed if specific physical, nutritional or psychological impairments will be identified during the assessment phase. Based on the data obtained during the multimodal assessment, different domains and levels of care will be prescribed, focusing on exercise training, and/or nutrition optimization, and/or distress-coping techniques. Different combinations of three domains will be utilized to maximize their synergistic anabolic effects. The duration of the program will be set at a minimum of three weeks.
Policlinico Universitario AOU Renato Dulbecco di Catanzaro
Catanzaro, Italy, Italy
RECRUITINGAOU Careggi
Florence, Italy, Italy
NOT_YET_RECRUITINGOspedale Galliera di Genova
Genova, Italy, Italy
NOT_YET_RECRUITINGASSTN GOM Niguarda
Milan, Italy, Italy
NOT_YET_RECRUITINGIRCCS Ospedale San Gerardo dei Tintori
Monza, Italy, Italy
NOT_YET_RECRUITINGOspedale Vanvitelli di Napoli
Napoli, Italy, Italy
RECRUITINGAOPD Padova
Padua, Italy, Italy
NOT_YET_RECRUITINGAzienda sanitaria universitaria Friuli Centrale (ASU FC)
Udine, Italy, Italy
NOT_YET_RECRUITINGIRCCS Ospedale San Raffaele
Milan, Milan, Italy
RECRUITINGAssess the impact of prehabilitation on severe postoperative complications among high-risk patients undergoing oncological surgery
The proportion of patients experiencing severe postoperative complications within 30 days after surgery defined as grade 3a or greater according to the Clavien-Dindo classification
Time frame: 30 days after surgery
Time to Functional Recovery (TFR)
Faster return to basal functional preoperative capacity in treatment group
Time frame: 30 days after surgery
Lenght of hospital stay (LOS)
Reduction of lenght of hospital stay in treatment group
Time frame: 30 days after surgery
Days at home up to 30 days after surgery (DAH-30)
The mean number of days at home in the first 30 days after surgery will be compared between groups
Time frame: 30 days after surgery
Complication severity
Assess complication severity as measured by the Comprehensive Complication Index (CCI)
Time frame: 30 days after surgery
Proportion of patients returning to preoperative functional walking capacity
Improvement in the return to basal functional preoperative capacity
Time frame: 30 days after surgery
Self-reported activity status and generic health related quality of life
Assess quality of life in the first 30 days at home after surgery using the EuroQol-5 Dimension (EQ-5D-5L) questionnaire, a validated tool for evaluating health-related quality of life. The outcome will be reported as the mean EQ-5D-5L index score and the mean EQ-VAS score measured at 30 days postoperatively.
Time frame: 30 days after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.